R&D | December 22, 2025
UK to get groundbreaking early detection test for bowel cancer
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment
5C Network’s groundbreaking platform aims to bring together diagnostic facilities and healthcare aggregators on a single platform to deliver an unparalleled patient experience
CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe
QIAreach SARS-CoV-2 antigen test, developed in collaboration with Ellume, is easy to use and provides accurate and objective results in 2 to 15 minutes
Subscribe To Our Newsletter & Stay Updated
